Articles Tagged With:
-
They're Back! CMS Audits Are Ratcheting Up
Hospitals have had a reprieve from record requests, denials, and appeals, but that’s about to change as CMS ramps up its auditing programs.
-
For Better Patient Care, Communicate Early and Often
In today’s healthcare world, communicating with other clinicians in the hospital and in post-acute provider organizations is essential to ensure patients receive the care they need to stay out of the hospital and the ED.
-
No Crystal Ball Needed to Know Where CMS May Focus
To get a good idea of what diagnoses CMS will add to the readmission reduction program or other value-based purchasing programs, look no further than the Hospital Inpatient Quality Reporting Program components.
-
Under New Leadership, CMS Continues Emphasis on Quality
Despite all of the changes in Washington, DC, the Centers for Medicare & Medicaid Services remains committed to providing high-quality, efficient, and cost-effective care.
-
Aberrant Conduction or Ventricular Bigeminy?
How would you interpret the tracing? Are these multifocal (multiform) premature ventricular contractions?
-
Clinical Briefs
In this section: managing diabetes; elective surgery; and nephrolithiasis patients.
-
Tisagenlecleucel Suspension (Kymriah)
Kymriah is indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia that is refractory or in second or later relapse.
-
What Is the Ideal Target for Blood Pressure Control?
Researchers organized a study to address quality-of-life outcomes based on recent blood pressure recommendations.
-
Do Antibiotics Reduce Hormonal Contraceptive Effectiveness?
Researchers conducted a systematic review of studies that evaluated the effect of concomitant non-rifamycin antibiotic use on hormonal contraceptive effectiveness. Although data are limited, there was no evidence to support the existence of drug interactions.
-
Screening for Prostate Cancer May Offer Survival Benefits
Using a mathematical model to account for differences in implementation and baseline screening, researchers reassessed mortality data from two major studies and discovered that screening led to a 25-30% reduction of prostate cancer death in both.